safingol has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, L; Fu, J; Liu, J; Wang, D; Xiao, X; Xie, T; Xie, Z; Yu, M; Zhang, Q | 1 |
| Antosik, K; Borowiec, M; Ciborowski, M; Fendler, W; Kretowski, A; Mlynarski, W; Parfieniuk, E; Pietrowska, K; Pyziak, A; Waszczykowska, A; Zmyslowska, A | 1 |
2 other study(ies) available for safingol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Serum metabolomics identified metabolite biomarkers and distinguished maturity-onset diabetes of the young from type 1 diabetes in the Chinese population.
Topics: Biomarkers; Chromatography, Liquid; Diabetes Mellitus, Type 1; East Asian People; Hepatocyte Nuclear Factor 1-alpha; Humans; Metabolomics; Phenylalanine; Tandem Mass Spectrometry | 2023 |
Serum Metabolic Fingerprinting Identified Putatively Annotated Sphinganine Isomer as a Biomarker of Wolfram Syndrome.
Topics: Adolescent; Adult; Biomarkers; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Humans; Male; Metabolome; Metabolomics; Sphingosine; Wolfram Syndrome; Young Adult | 2017 |